Sheehan Erin, Brockhaus Kara K, Huebner Marianne, Ma Wenjuan, Kolli Nivya, Cleary Robert K
Department of Surgery, Trinity Health Ann Arbor, Ann Arbor, MI, 48106, USA.
Department of Pharmacy, Trinity Health Ann Arbor, Ann Arbor, MI, USA.
Surg Endosc. 2025 May 2. doi: 10.1007/s00464-025-11752-y.
Postoperative ileus (POI) after colorectal surgery is associated with prolonged hospital length of stay, readmission, and higher costs of care. POI may be unpredictable and even uncomplicated enhanced recovery elective minimally invasive colorectal operations may be complicated by ileus and readmission related to ileus. Determining if there are modifiable factors associated with ileus may suggest quality improvement interventions designed to decrease ileus. The aim of this study was to identify patient characteristics associated with ileus and the relationship with postoperative opioids.
This is a single institution retrospective analysis of robotic right and left colectomy in a prospectively maintained institutional colorectal surgery database from 1/1/2018 to 7/31/2024. The primary outcome was postoperative ileus. Mediation analysis was used to examine the association of patient factors with ileus mediated by postoperative opioids.
There were 394 left and 267 right colectomies that met inclusion criteria. Neoplasia was the operative diagnosis for 89.5% of right colectomies and diverticular disease for 78.7% of left colectomies (p < 0.001). Median postoperative hospital length of stay was 2.0 days. Ileus occurred in 5.6% of the patient population. An analysis with postoperative opioids (intravenous or oral) as mediating variable showed that postoperative opioids were associated with ileus (OR 2.83, CI 1.18-14.67). While older patients had less opioid requirements (OR 0.96, CI 0.95-0.98), the risk of ileus (OR 1.03, CI 1.00-1.06) was the same for older patients with and without opioids. A decrease in opioid prescriptions at discharge was seen over time (p < 0.001).
Postoperative opioids were the only modifiable risk factor for ileus after robotic segmental colectomy. The risk of ileus for other factors associated with ileus did not increase when opioids were added postoperatively. Considering other opioid-sparing enhanced recovery pathway options and increased adoption of the minimally invasive surgical approach may lessen this vexing postoperative complication.
结直肠手术后的术后肠梗阻(POI)与住院时间延长、再次入院以及更高的护理成本相关。POI可能无法预测,甚至无并发症的强化康复择期微创结直肠手术也可能因肠梗阻及与肠梗阻相关的再次入院而变得复杂。确定是否存在与肠梗阻相关的可改变因素可能提示旨在减少肠梗阻的质量改进干预措施。本研究的目的是确定与肠梗阻相关的患者特征以及与术后阿片类药物的关系。
这是一项对2018年1月1日至2024年7月31日前瞻性维护的机构结直肠手术数据库中机器人辅助右半结肠切除术和左半结肠切除术的单机构回顾性分析。主要结局是术后肠梗阻。采用中介分析来检验患者因素与由术后阿片类药物介导的肠梗阻之间的关联。
有394例左半结肠切除术和267例右半结肠切除术符合纳入标准。肿瘤形成是89.5%的右半结肠切除术的手术诊断,憩室病是78.7%的左半结肠切除术的手术诊断(p<0.001)。术后中位住院时间为2.0天。5.6%的患者发生了肠梗阻。以术后阿片类药物(静脉或口服)作为中介变量的分析表明,术后阿片类药物与肠梗阻相关(OR 2.83,CI 1.18 - 14.67)。虽然老年患者对阿片类药物的需求量较少(OR 0.96,CI 0.95 - 0.98),但使用和未使用阿片类药物的老年患者发生肠梗阻的风险相同(OR 1.03,CI 1.00 - 1.06)。随着时间的推移,出院时阿片类药物处方量有所减少(p<0.001)。
术后阿片类药物是机器人辅助节段性结肠切除术后肠梗阻唯一可改变的危险因素。当术后添加阿片类药物时,与肠梗阻相关的其他因素导致肠梗阻的风险并未增加。考虑其他节省阿片类药物的强化康复途径选项以及增加微创外科手术方法的采用可能会减轻这种令人烦恼的术后并发症。